Correlation Between Electronic Patient-Reported Outcomes and Biological Markers of Key Parameters in Acute Radiation Cystitis Among Patients With Prostate Cancer (RABBIO): Prospective Observational Study
2024

Study on Radiation Cystitis in Prostate Cancer Patients

Sample size: 20 publication Evidence: moderate

Author Information

Author(s): Carole Helissey, Sophie Cavallero, Nathalie Guitard, Hélène Thery, Charles Parnot, Antoine Schernberg, Imen Aissa, Florent Raffin, Christine Le Coz, Stanislas Mondot, Christos Christopoulos, Karim Malek, Emmanuelle Malaurie, Pierre Blanchard, Cyrus Chargari, Sabine Francois

Primary Institution: Bégin Military Hospital

Hypothesis

The study aims to investigate the correlation between blood and urinary biomarkers and the intensity of acute radiation cystitis symptoms and quality of life in patients undergoing localized prostate cancer radiotherapy.

Conclusion

The study suggests that elevated levels of certain inflammatory proteins in blood and urine are associated with the deterioration of quality of life during radiotherapy for prostate cancer.

Supporting Evidence

  • 401 adverse events questionnaires were collected over the study duration.
  • Significant increase in serum and urine levels of inflammatory proteins was observed at week 12.
  • Baseline serum and urine M-CSF concentrations showed a significant negative correlation with FACT-P scores.

Takeaway

Doctors looked at how certain proteins in the blood and urine of prostate cancer patients can show how bad their bladder problems are after radiation treatment.

Methodology

The study analyzed blood and urinary biomarkers before and during radiotherapy, while patients reported their symptoms and quality of life using questionnaires.

Potential Biases

The exploratory nature of the study and the small sample size may introduce bias in the results.

Limitations

The study was conducted on a small number of patients, which may limit the generalizability of the findings.

Participant Demographics

The median age of participants was 76 years, with 65% having at least one comorbidity, and 35% having type 2 diabetes.

Statistical Information

P-Value

P=.04 and P=.02

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.2196/48225

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication